Abstract

7009 Background: No studies to date have evaluated the role of RIC alloHCT compared to autologous (auto) HCT in pts with G-3 FL, in the rituximab-era. Methods: Adult pts with relapsed/refractory G-...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call